Influenza Hemagglutinin (HA) Peptide: Verified Tag for Protein Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence YPYDVPDYA) is a widely used epitope tag for protein detection and purification workflows. This nine-amino acid synthetic peptide, available as APExBIO’s A6004, enables competitive elution of HA-tagged proteins in immunoprecipitation with anti-HA antibodies (product information). Its purity is confirmed to exceed 98% by HPLC and MS. The peptide exhibits excellent solubility in DMSO, ethanol, and water, supporting flexible assay design. Benchmarked studies and best-practice protocols document its reproducibility and efficiency for protein interaction studies and molecular workflows (Dong et al., 2025).

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide is derived from the influenza A virus hemagglutinin protein, specifically the YPYDVPDYA motif. This linear epitope is recognized with high specificity by anti-HA monoclonal antibodies, making it an ideal universal protein tag. The HA tag enables standardized detection, purification, and quantification of recombinant proteins, regardless of their native structure or origin (APExBIO). Use of epitope tags like HA streamlines molecular workflows, allowing researchers to employ a single high-affinity antibody across different targets. This approach increases reproducibility and comparability in protein expression and interaction studies. For example, in colorectal cancer metastasis models, such tags facilitate precise detection of engineered protein constructs during mechanistic validation (Dong et al., 2025).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA tag peptide works by mimicking the epitope sequence recognized by anti-HA antibodies. When used as a competitor in immunoprecipitation or affinity purification assays, the synthetic HA peptide (YPYDVPDYA) binds to the paratope of anti-HA antibodies, displacing HA-tagged fusion proteins from antibody-conjugated beads. This competitive binding enables specific elution and recovery of tagged proteins without harsh chemicals or denaturing conditions (product documentation). The tag is small (9 residues), minimizing interference with protein folding or function, and its DNA sequence is easily incorporated into recombinant constructs. Optimal binding occurs at neutral pH in standard immunoprecipitation buffers.

Evidence & Benchmarks

• APExBIO's Influenza Hemagglutinin (HA) Peptide (A6004) is confirmed to be >98% pure by HPLC and mass spectrometry (product data).
• The HA peptide sequence (YPYDVPDYA) is the canonical linear epitope recognized by monoclonal anti-HA antibodies, supporting its universal utility as a protein tag (Dong et al., 2025).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water, enabling high-concentration stock solutions (APExBIO).
• HA peptide enables reproducible competitive elution of HA-tagged proteins in immunoprecipitation workflows, as documented in both peer-reviewed studies and scenario-driven application guides (internal guide).
• In advanced cancer research, HA tag-based detection supports mechanistic studies of protein-protein interactions, such as PRMT5 degradation and AKT/mTOR pathway modulation (Dong et al., 2025).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is foundational for:

• Protein detection by Western blot, ELISA, and immunocytochemistry using anti-HA antibodies.
• Affinity purification of HA-tagged proteins via competitive elution in immunoprecipitation assays (detailed guidance).
• Protein-protein interaction mapping in mammalian, yeast, and bacterial systems.

However, users should recognize the following:

Common Pitfalls or Misconceptions

• Not suitable for in vivo therapeutic use: The HA peptide is designed for laboratory applications only and is not validated for clinical or in vivo therapeutic use.
• Epitope masking: Fusion protein conformation or steric hindrance can occasionally obscure the HA tag, reducing antibody accessibility (see contrasted workflow scenarios).
• Overloading antibody capacity: Excess HA peptide can saturate the antibody, leading to incomplete elution or nonspecific binding.
• Batch variability in custom peptides: Only high-purity, validated peptides (such as APExBIO's A6004) should be used to avoid inconsistent results.
• Not a substitute for sequence/structure validation: The HA tag does not confirm correct protein folding or post-translational modifications.

This article extends prior analyses (e.g., Precision Tag for Protein Purification) by benchmarking purity, solubility, and application scenarios using current product and literature data, providing updated context for protocol optimization.

Workflow Integration & Parameters

For optimal results with the HA tag peptide, adhere to established protocols and storage recommendations. Below are key, structured parameters:

Protocol Parameters

• Peptide concentration for elution: 0.5–2 mg/mL in immunoprecipitation buffer; titrate as needed for complete elution.
• Solvent selection: DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), or water (≥46.2 mg/mL); select based on downstream assay compatibility (specifications).
• Storage conditions: Store lyophilized peptide desiccated at -20°C. Avoid repeated freeze-thaw cycles and long-term storage of peptide solutions.
• Antibody selection: Use validated monoclonal anti-HA antibodies for detection and elution; confirm compatibility with your assay.
• Buffer pH: Maintain neutral pH (7.2–7.5) for optimal antibody-peptide interaction.

For troubleshooting and protocol customization, consult scenario-driven recommendations in recent internal workflow guides (see application Q&A).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide is a gold-standard epitope tag for the detection and purification of recombinant proteins in basic and translational research. Its robust performance, high purity, and reproducibility are supported by both peer-reviewed studies and manufacturer validation (Dong et al., 2025). As protein–protein interaction studies evolve, the HA tag’s modularity and specificity will continue to support reproducible, scalable workflows. However, as with all affinity tags, limitations such as epitope masking or overloading must be managed by careful protocol design and validation. APExBIO's A6004 product remains a reliable standard for laboratories seeking consistent results in protein detection and purification.